Fertility Challenges Treatment Do Fertility Drugs Increase Your Risk of Getting Cancer? By Rachel Gurevich, RN Rachel Gurevich, RN Facebook LinkedIn Twitter Rachel Gurevich is a fertility advocate, author, and recipient of The Hope Award for Achievement, from Resolve: The National Infertility Association. Learn about our editorial process Updated on September 23, 2020 Medically reviewed by Leyla Bilali, RN Medically reviewed by Leyla Bilali, RN Leyla Bilali, RN is a registered nurse, fertility nurse, and fertility consultant in the New York City area. She works in house at a reputable private clinic in New York City while also seeing her own clients through her concierge fertility consulting and nursing services business. Learn about our Medical Review Board Print JGI/Tom Grill / Getty Images Table of Contents View All Table of Contents Cancer Risk Ovarian Tumors Endometrial Cancer Breast Cancer Ovarian Cancer Do fertility drugs cause cancer? What about IVF treatment? It is true that a few studies seemed to find a connection between fertility drug use and an increased risk of breast or uterine cancer, specifically with the drug Clomid. All medications, including fertility drugs, come with risks. But should you be concerned about an increased cancer risk? Let's take a look. Fertility Drugs and Cancer Risk In 2005, a widely publicized study reported that Clomid use might increase the risk of uterine cancer. However, since that time, more studies have been done, and most have found no significant increase in cancer risk after Clomid use. In fact, a 2019 review—which concluded that there is "no definitive relationship between the use of fertility drugs and cancer"—found that because estrogen helps protect against colorectal cancer, the risk of cancer should decrease in women who use fertility drugs. The problem with many of these studies is they don't take into account other potential risk factors for uterine cancer. Namely, if a woman never experiences pregnancy, her risk of cancer increases. Also, obesity is not only a risk factor for infertility, but it is also a risk factor for cancer. It may not have been the fertility drugs at all. Instead, the increased incidence may be attributed to the reason behind infertility itself or any number of other factors not taken into account in this study. Many studies have found a possible connection between certain causes of infertility—such as diet or obesity—and an increased risk of cancer. Another common problem with these studies is the sample sizes were too small. Why Your Weight May Matter When You're Trying to Conceive Ovarian Cancer Risk The strongest evidence that Clomid and other ovarian-stimulating drugs do not increase the risk of ovarian cancer comes from a Cochrane Review. The review included studies from 1990 through February 2013. The studies compiled together included 182,972 women. Seven of the studies found no evidence of increased ovarian cancer in women who use any fertility drug (including Clomid) when comparing their risk to other women with fertility problems who did not use fertility drugs. According to the review, studies that did find increased cancer risk were not reliable because they failed to take into consideration the risk of infertility itself or the sample size was too small to draw conclusions. Borderline Ovarian Tumors and IVF The Cochrane review did find a possible increased risk of borderline ovarian tumors in women who went through IVF treatment. This risk was not present after Clomid or Clomid with gonadotropins treatment alone. The treatment of borderline ovarian tumors isn’t as intense and involved as with typical ovarian tumors, and the prognosis for women with a borderline tumor is very good. A 2015 study tried to further investigate the possible risk of borderline ovarian tumors and fertility treatment. What they found was that there was no strong link between borderline ovarian tumors and fertility drug use. There may be a possible connection between borderline ovarian tumors and progesterone supplementation. Researchers found that the risk of borderline ovarian tumors was higher for women who used progesterone compared to those who never did and higher in women who had four or more cycles of progesterone supplementation. That said, the number of women in the study with borderline tumors was small. Follow-up studies with larger groups of women are needed. Endometrial Cancer Risk Could fertility drugs increase the risk of endometrial cancer? A Cochrane Review of 19 studies concluded that due to poor study design, it’s not possible to say with any certainty whether endometrial cancer risk increases after exposure to fertility drugs. There did seem to be a possible increased risk in women who had very high doses of Clomid (greater than 2,000 mg—the average starting dose is only 50 mg) and took Clomid for seven or more cycles. However, the current research wasn’t able to distinguish whether that increased risk was due to Clomid or underlying fertility factors. For example, PCOS is known to increase the risk of developing endometrial cancer. Long-Term Risk of Breast Cancer After IVF Could IVF (in vitro fertilization) treatment increase your risk of breast cancer? The current research says not likely. One of the largest studies to date included 25,108 women, with an average follow-up of 21 years after treatment. These were women from the Netherlands, who received IVF treatment between 1980 and 1995. There was no increased risk of breast cancer in women who received IVF compared to those who received non-IVF fertility treatments. Interestingly, researchers found the risk of breast cancer was lower for women who had seven or more IVF cycles compared to women who had one or two cycles. It’s unclear why this is. IVF and Ovarian Cancer A 2018 study analyzed the cancer risk in women who had gone through IVF treatment, including over 250,000 British women and spanning treatment cycles between 1991 and 2010. The good news was that they found no increased risk of breast or uterine cancer in the former IVF patients. The bad news is that they found an increased risk of ovarian cancer. While women who had never gone through IVF had an 11 in 10,000 chance of developing ovarian cancer, the IVF patients had 15 in 10,000 odds. The increase in risk is small but important to recognize. Like in the studies mentioned above, the consensus is that the increased risk isn't caused by IVF treatment itself but the fact that the women needed treatment. Infertility and the need for IVF are suspected as the risk, not the fertility drugs used during treatment With that said, the study also found that the cancer risk was higher in the first three years after treatment. So, it's not possible to completely rule out that fertility drugs played a role in the cancer risk. Close monitoring in the years after IVF treatment may be smart. A Word From Verywell The consensus is that fertility drugs do not increase your risk of developing breast or uterine cancer. Also, some studies have looked at fertility drug use and other kinds of cancers (thyroid and skin cancers, for example), and they have also found no significant increase in risk. However, because infertility itself is a risk factor for cancer, follow-up after diagnosis is recommended. Women with primary infertility, who never become pregnant and give birth, as well as women diagnosed with endometriosis, may particularly have an increased risk of developing cancer. PCOS, a common cause of infertility, is also known to come with an increased risk of developing endometrial cancer. It's possible that very high doses of Clomid, or treatment that extends beyond seven cycles, may increase the risk of endometrial cancer. But the current evidence can't distinguish whether this increased risk comes from Clomid or infertility itself. Also, it's important to keep in mind that the technology of fertility treatment is changing. Lower doses of drugs are now being used than in the early days of treatment, and many of the studies on cancer and fertility treatment include women treated in the 1980s, more aggressively than they might be today. Studies on cancer and fertility treatment also require long-term follow-up. It may be decades before we can really say what impact fertility treatment at age 35 will have on a woman who is 65 or 70 years old. While more research must be done, for now, fertility drugs are (mostly) off the hook. In Vitro Fertilization (IVF): What to Expect 9 Sources Verywell Family uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Momenimovahed Z, Taheri S, Tiznobaik A, Salehiniya H. Do the fertility drugs increase the risk of cancer? A review study. Front Endocrinol (Lausanne). 2019;10:313. doi:10.3389/fendo.2019.00313 De pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546. doi:10.1155/2013/291546 National Cancer Institute. Risk factors for cancer. Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013;(8):CD008215. doi:10.1002/14651858.CD008215.pub2 Bjørnholt SM, Kjaer SK, Nielsen TS, Jensen A. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study. Hum Reprod. 2015;30(1):222-31. doi:10.1093/humrep/deu297 Skalkidou A, Sergentanis TN, Gialamas SP, et al. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database Syst Rev. 2017;3:CD010931. doi:10.1002/14651858.CD010931.pub2 Van den belt-dusebout AW, Spaan M, Lambalk CB, et al. Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer. JAMA. 2016;316(3):300-12. doi:10.1001/jama.2016.9389 Williams CL, Jones ME, Swerdlow AJ, et al. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ. 2018;362:k2644. doi:10.1136/bmj.k2644 Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782-5. doi:10.1016/j.steroids.2013.04.004 By Rachel Gurevich, RN Rachel Gurevich is a fertility advocate, author, and recipient of The Hope Award for Achievement, from Resolve: The National Infertility Association. She is a professional member of the Association of Health Care Journalists and has been writing about women’s health since 2001. Rachel uses her own experiences with infertility to write compassionate, practical, and supportive articles. See Our Editorial Process Meet Our Review Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit